You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR APRACLONIDINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for APRACLONIDINE HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00567411 ↗ Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty Unknown status Walter Reed Army Medical Center N/A 2006-08-01 The purpose of the study is to compare the safety and efficacy of two drops used to lower eye pressure when given prior to a glaucoma laser procedure.
NCT05045248 ↗ Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis Completed American University of Beirut Medical Center Phase 2 2020-06-01 This study is aimed at assessing the efficacy of Apraclonidine eye drops in the treatment of ptosis secondary to myasthenia gravis.
NCT05167760 ↗ Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis Not yet recruiting University of Alabama at Birmingham Phase 4 2022-02-01 The purpose of this study is to determine efficacy of apraclonidine for patients with ocular synkinesis, who are seen in the UAB Facial Nerve Clinic.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for APRACLONIDINE HYDROCHLORIDE

Condition Name

Condition Name for APRACLONIDINE HYDROCHLORIDE
Intervention Trials
Facial Nerve Palsy 1
Glaucoma 1
Myasthenia Gravis 1
Ocular Hypertension 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for APRACLONIDINE HYDROCHLORIDE
Intervention Trials
Ocular Hypertension 1
Synkinesis 1
Glaucoma 1
Facial Paralysis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for APRACLONIDINE HYDROCHLORIDE

Trials by Country

Trials by Country for APRACLONIDINE HYDROCHLORIDE
Location Trials
United States 2
Lebanon 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for APRACLONIDINE HYDROCHLORIDE
Location Trials
Alabama 1
District of Columbia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for APRACLONIDINE HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for APRACLONIDINE HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for APRACLONIDINE HYDROCHLORIDE
Clinical Trial Phase Trials
Completed 1
Not yet recruiting 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for APRACLONIDINE HYDROCHLORIDE

Sponsor Name

Sponsor Name for APRACLONIDINE HYDROCHLORIDE
Sponsor Trials
Walter Reed Army Medical Center 1
American University of Beirut Medical Center 1
University of Alabama at Birmingham 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for APRACLONIDINE HYDROCHLORIDE
Sponsor Trials
Other 2
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.